{"component": "clause", "props": {"groups": [{"snippet": "Until such time as Nanobiotix and Lian execute a Supply Agreement, at Lian\u2019s request, Nanobiotix will, on Lian\u2019s behalf, place orders with its suppliers for Licensed Products for use by Lian for Development purposes, [***]. After delivery, Nanobiotix will invoice Lian for the Transfer Price for such Licensed Product and Lian will pay Nanobiotix within [***] days after receipt of such invoice. Nanobiotix will provide all Licensed Products provided pursuant to this Section 6.2 with those product warranties and corresponding remedies that Nanobiotix receives from its supplier.", "snippet_links": [{"key": "supply-agreement", "type": "definition", "offset": [49, 65]}, {"key": "place-orders", "type": "definition", "offset": [121, 133]}, {"key": "development-purposes", "type": "definition", "offset": [195, 215]}, {"key": "after-delivery", "type": "clause", "offset": [224, 238]}, {"key": "transfer-price", "type": "definition", "offset": [277, 291]}, {"key": "after-receipt-of", "type": "clause", "offset": [365, 381]}, {"key": "will-provide", "type": "clause", "offset": [407, 419]}, {"key": "products-provided", "type": "clause", "offset": [433, 450]}, {"key": "pursuant-to", "type": "definition", "offset": [451, 462]}, {"key": "section-62", "type": "clause", "offset": [468, 479]}, {"key": "product-warranties", "type": "clause", "offset": [491, 509]}], "samples": [{"hash": "cY0AWAWUjNB", "uri": "/contracts/cY0AWAWUjNB#interim-supply", "label": "License, Development and Commercialization Agreement (Nanobiotix S.A.)", "score": 33.2655715264, "published": true}, {"hash": "qH40gYWW6A", "uri": "/contracts/qH40gYWW6A#interim-supply", "label": "License, Development and Commercialization Agreement (Nanobiotix S.A.)", "score": 32.6851471595, "published": true}, {"hash": "2Dlhg6YAjRL", "uri": "/contracts/2Dlhg6YAjRL#interim-supply", "label": "License, Development and Commercialization Agreement (LianBio)", "score": 32.4880219028, "published": true}], "size": 4, "hash": "433410b8123a8696abaf264613e2d1a7", "id": 1}, {"snippet": "In the case where Alder notifies BMS in writing within [***] after the date of termination that Alder desires BMS to provide to Alder an interim supply of Licensed Compound and/or Licensed Product, BMS shall use Diligent Efforts to provide such supply in accordance with the terms of this Section 13.5(g). BMS\u2019 obligation to provide such supply under this Section 13.5(g) shall only be for the period of [***] from the date of termination and BMS shall have no obligation to supply Licensed Compound and/or Licensed Product to Alder after such [***] period or, if earlier, Alder\u2019s notification to BMS that Alder has obtained alternative, validated source of supply of Licensed Compound and/or Licensed Product, as applicable. Upon such request by Alder for such interim supply, the [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Parties shall enter into a supply agreement pursuant to which BMS will use Diligent Efforts to supply Licensed Compound and/or Product to Alder for such period ending [***] after the termination date. Alder shall use all reasonable commercial efforts to procure an alternative supply of Licensed Compound and/or Licensed Product as soon as possible following the effective date of the applicable termination. The Licensed Compound and/or Licensed Product shall be supplied at a supply price equal to BMS\u2019 Manufacturing Costs for such Licensed Compound or Product supplied. The supply agreement shall reflect these provisions and shall contain such other customary terms as the Parties deem appropriate.", "snippet_links": [{"key": "in-the-case", "type": "clause", "offset": [0, 11]}, {"key": "in-writing", "type": "clause", "offset": [37, 47]}, {"key": "date-of-termination", "type": "clause", "offset": [71, 90]}, {"key": "supply-of-licensed-compound", "type": "clause", "offset": [145, 172]}, {"key": "licensed-product", "type": "clause", "offset": [180, 196]}, {"key": "diligent-efforts", "type": "definition", "offset": [212, 228]}, {"key": "in-accordance-with", "type": "definition", "offset": [252, 270]}, {"key": "terms-of", "type": "definition", "offset": [275, 283]}, {"key": "obligation-to-provide", "type": "clause", "offset": [311, 332]}, {"key": "period-of", "type": "definition", "offset": [394, 403]}, {"key": "termination-and", "type": "clause", "offset": [427, 442]}, {"key": "no-obligation-to-supply", "type": "clause", "offset": [458, 481]}, {"key": "notification-to", "type": "clause", "offset": [581, 596]}, {"key": "source-of-supply", "type": "definition", "offset": [648, 664]}, {"key": "certain-confidential-information", "type": "clause", "offset": [790, 822]}, {"key": "contained-in", "type": "definition", "offset": [823, 835]}, {"key": "the-securities-and-exchange-commission", "type": "clause", "offset": [885, 923]}, {"key": "pursuant-to-rule", "type": "clause", "offset": [924, 940]}, {"key": "securities-act-of-1933", "type": "clause", "offset": [955, 977]}, {"key": "as-amended", "type": "definition", "offset": [979, 989]}, {"key": "period-ending", "type": "definition", "offset": [1144, 1157]}, {"key": "after-the-termination-date", "type": "clause", "offset": [1164, 1190]}, {"key": "reasonable-commercial-efforts", "type": "definition", "offset": [1212, 1241]}, {"key": "alternative-supply", "type": "clause", "offset": [1256, 1274]}, {"key": "as-soon-as-possible", "type": "definition", "offset": [1320, 1339]}, {"key": "applicable-termination", "type": "definition", "offset": [1376, 1398]}, {"key": "supply-price", "type": "definition", "offset": [1469, 1481]}, {"key": "equal-to", "type": "definition", "offset": [1482, 1490]}, {"key": "manufacturing-costs", "type": "definition", "offset": [1496, 1515]}, {"key": "the-supply-agreement", "type": "clause", "offset": [1564, 1584]}, {"key": "other-customary-terms", "type": "clause", "offset": [1639, 1660]}, {"key": "the-parties", "type": "definition", "offset": [1664, 1675]}], "samples": [{"hash": "65Tpka9XIGr", "uri": "/contracts/65Tpka9XIGr#interim-supply", "label": "Collaboration and License Agreement (Alder Biopharmaceuticals Inc)", "score": 25.3285420945, "published": true}, {"hash": "hmRsDoxl6P3", "uri": "/contracts/hmRsDoxl6P3#interim-supply", "label": "Collaboration and License Agreement (Alder Biopharmaceuticals Inc)", "score": 25.2108145106, "published": true}], "size": 4, "hash": "e974f45e92f6f7c608b6f3a17c5f570b", "id": 2}, {"snippet": "In the event of any termination pursuant to Section 11.2, Section 11.3, or Section 11.4, at PDL\u2019s request, BMS shall supply, or cause to be supplied, to PDL sufficient quantities of Product to satisfy PDL\u2019s and its Affiliate\u2019s requirements for Product for a period of up to [****]* following the effective date of termination, as PDL may require until PDL can itself assume or transition to a Third Party such manufacturing responsibilities; provided that PDL shall use commercially reasonable efforts to affect such assumption (or transition) as promptly as practicable. Such supply shall be at a price equal to BMS\u2019 fully-burdened manufacturing costs for such Product(s). Any such supply will be made pursuant to a supply agreement between the parties with typical provisions relating to quality, forecasting and ordering to forecast, force majeure and product liability and indemnity. In the event that BMS has one or more agreements with Third Party manufacturers with respect to the manufacture of a Licensed Product, at PDL\u2019s request, BMS shall use commercially reasonable efforts to transfer its rights and obligations under such agreement(s) to PDL upon any such termination.", "snippet_links": [{"key": "in-the-event-of", "type": "definition", "offset": [0, 15]}, {"key": "termination-pursuant-to-section", "type": "clause", "offset": [20, 51]}, {"key": "section-113", "type": "clause", "offset": [58, 70]}, {"key": "requirements-for", "type": "clause", "offset": [227, 243]}, {"key": "period-of", "type": "definition", "offset": [258, 267]}, {"key": "effective-date-of-termination", "type": "clause", "offset": [296, 325]}, {"key": "a-third-party", "type": "clause", "offset": [391, 404]}, {"key": "manufacturing-responsibilities", "type": "definition", "offset": [410, 440]}, {"key": "provided-that", "type": "clause", "offset": [442, 455]}, {"key": "use-commercially-reasonable-efforts", "type": "clause", "offset": [466, 501]}, {"key": "equal-to", "type": "definition", "offset": [604, 612]}, {"key": "manufacturing-costs", "type": "definition", "offset": [633, 652]}, {"key": "pursuant-to-a", "type": "definition", "offset": [703, 716]}, {"key": "agreement-between-the-parties", "type": "clause", "offset": [724, 753]}, {"key": "provisions-relating-to", "type": "clause", "offset": [767, 789]}, {"key": "forecasting-and-ordering", "type": "clause", "offset": [799, 823]}, {"key": "force-majeure", "type": "definition", "offset": [837, 850]}, {"key": "product-liability-and-indemnity", "type": "clause", "offset": [855, 886]}, {"key": "third-party-manufacturers", "type": "clause", "offset": [942, 967]}, {"key": "with-respect-to", "type": "clause", "offset": [968, 983]}, {"key": "licensed-product", "type": "clause", "offset": [1005, 1021]}, {"key": "to-transfer", "type": "clause", "offset": [1087, 1098]}, {"key": "rights-and-obligations", "type": "definition", "offset": [1103, 1125]}], "samples": [{"hash": "kwJD9zWsUL2", "uri": "/contracts/kwJD9zWsUL2#interim-supply", "label": "Collaboration Agreement (Facet Biotech Corp)", "score": 21.0, "published": true}, {"hash": "iufFmk0qVhC", "uri": "/contracts/iufFmk0qVhC#interim-supply", "label": "Collaboration Agreement (PDL Biopharma, Inc.)", "score": 21.0, "published": true}, {"hash": "cgflPQ4HIc5", "uri": "/contracts/cgflPQ4HIc5#interim-supply", "label": "Collaboration Agreement (Facet Biotech Corp)", "score": 21.0, "published": true}], "size": 3, "hash": "ec4f706ce0d0d665b688070577339429", "id": 3}, {"snippet": "In the event of any termination pursuant to Section 11.2, or Section 11.3 (where BMS is the breaching Party), in each case [*], at the written request of EPC (or its sublicensee), BMS shall supply, or cause to be supplied, to EPC or such sublicensee sufficient quantities of Product to satisfy EPC (or its sublicensee\u2019s)requirements for Product for a period of up to [*] following the effective date of termination, as EPC or its sublicensee may require until EPC or its sublicensee can itself assume or transition to a Third Party such manufacturing responsibilities; provided, however that EPC or its sublicensee shall use Diligent Efforts to affect such assumption (or transition) as promptly as practicable. Such supply shall be [*] such Product(s) with respect to development supply, and shall be [*] such Product(s) with respect to commercial supply. Any such supply will be made pursuant to a supply agreement between the Parties with typical provisions relating to quality, forecasting and ordering to forecast, force majeure and product liability and indemnity. In the event that BMS has one or more agreements with Third Party manufacturers with respect to the manufacture of a Product, at EPC (or its sublicensee\u2019s) request, BMS shall use commercially reasonable efforts to transfer its rights and obligations under such agreement(s) to EPC upon any such termination.", "snippet_links": [{"key": "in-the-event-of", "type": "definition", "offset": [0, 15]}, {"key": "termination-pursuant-to-section", "type": "clause", "offset": [20, 51]}, {"key": "section-113", "type": "clause", "offset": [61, 73]}, {"key": "breaching-party", "type": "clause", "offset": [92, 107]}, {"key": "each-case", "type": "definition", "offset": [113, 122]}, {"key": "written-request", "type": "definition", "offset": [135, 150]}, {"key": "period-of", "type": "definition", "offset": [351, 360]}, {"key": "effective-date-of-termination", "type": "clause", "offset": [385, 414]}, {"key": "a-third-party", "type": "clause", "offset": [518, 531]}, {"key": "manufacturing-responsibilities", "type": "definition", "offset": [537, 567]}, {"key": "diligent-efforts", "type": "definition", "offset": [625, 641]}, {"key": "development-supply", "type": "clause", "offset": [769, 787]}, {"key": "commercial-supply", "type": "definition", "offset": [838, 855]}, {"key": "pursuant-to-a", "type": "definition", "offset": [886, 899]}, {"key": "agreement-between-the-parties", "type": "clause", "offset": [907, 936]}, {"key": "provisions-relating-to", "type": "clause", "offset": [950, 972]}, {"key": "forecasting-and-ordering", "type": "clause", "offset": [982, 1006]}, {"key": "force-majeure", "type": "definition", "offset": [1020, 1033]}, {"key": "product-liability-and-indemnity", "type": "clause", "offset": [1038, 1069]}, {"key": "third-party-manufacturers", "type": "clause", "offset": [1125, 1150]}, {"key": "use-commercially-reasonable-efforts", "type": "clause", "offset": [1246, 1281]}, {"key": "to-transfer", "type": "clause", "offset": [1282, 1293]}, {"key": "rights-and-obligations", "type": "definition", "offset": [1298, 1320]}], "samples": [{"hash": "jC7NerxKQHp", "uri": "/contracts/jC7NerxKQHp#interim-supply", "label": "Collaboration Agreement (Exelixis, Inc.)", "score": 27.5872689938, "published": true}, {"hash": "fxkopCP0FKV", "uri": "/contracts/fxkopCP0FKV#interim-supply", "label": "Collaboration Agreement (Exelixis Inc)", "score": 22.5879534565, "published": true}], "size": 3, "hash": "6dfde4b0ee1e29d3e0ffd139786da958", "id": 4}, {"snippet": "The Parties agree that any inventories of KB001-A and/or [***] (as defined in the Agreement) in Sanofi\u2019s or its Affiliates or subcontractors\u2019 possession are hereby assigned to KaloBios and Sanofi shall cooperate with KaloBios to transfer such inventories to KaloBios or its designee as soon as KaloBios or its designee confirms that it is ready to receive such Materials following the Termination Agreement Effective Date. The Parties agree that Sanofi\u2019s obligations regarding supply of Licensed Product under the Agreement are terminated as of the Termination Agreement Effective Date and no further notice of termination, for example, of the Supply Agreement between the Parties dated as of October 10, 2010, as amended, is necessary, and that KaloBios waives the right to any such notice under that Supply Agreement. CONFIDENTIAL TREATMENT REQUESTED (g)Transition Assistance. Sanofi shall provide such assistance, at no cost to KaloBios, as may be reasonably necessary or useful for KaloBios to commence or continue Developing or Commercializing Licensed Products in the Sanofi Field in the Territory, to the extent Sanofi is then performing or having performed such activities, including transferring or amending as appropriate, upon request of KaloBios, any agreements or arrangements with Third Party vendors with respect to Licensed Products. To the extent that any such contract between Sanofi and a Third Party is not assignable to KaloBios, then Sanofi shall reasonably cooperate with KaloBios to arrange to continue to and provide such services from such entity. In no event shall Sanofi be required to perform any transition assistance after the Transition Completion Date.", "snippet_links": [{"key": "the-parties-agree-that", "type": "clause", "offset": [0, 22]}, {"key": "in-the-agreement", "type": "clause", "offset": [75, 91]}, {"key": "cooperate-with", "type": "clause", "offset": [202, 216]}, {"key": "to-transfer", "type": "clause", "offset": [226, 237]}, {"key": "to-receive", "type": "definition", "offset": [345, 355]}, {"key": "agreement-effective-date", "type": "clause", "offset": [397, 421]}, {"key": "supply-of-licensed-product", "type": "clause", "offset": [477, 503]}, {"key": "notice-of-termination", "type": "clause", "offset": [601, 622]}, {"key": "for-example", "type": "definition", "offset": [624, 635]}, {"key": "agreement-between-the-parties", "type": "clause", "offset": [651, 680]}, {"key": "dated-as-of", "type": "definition", "offset": [681, 692]}, {"key": "as-amended", "type": "definition", "offset": [711, 721]}, {"key": "right-to", "type": "definition", "offset": [766, 774]}, {"key": "confidential-treatment-requested", "type": "definition", "offset": [820, 852]}, {"key": "transition-assistance", "type": "definition", "offset": [856, 877]}, {"key": "at-no-cost", "type": "definition", "offset": [917, 927]}, {"key": "reasonably-necessary", "type": "clause", "offset": [951, 971]}, {"key": "licensed-products", "type": "clause", "offset": [1049, 1066]}, {"key": "sanofi-field", "type": "definition", "offset": [1074, 1086]}, {"key": "in-the-territory", "type": "clause", "offset": [1087, 1103]}, {"key": "to-the-extent", "type": "clause", "offset": [1105, 1118]}, {"key": "upon-request", "type": "definition", "offset": [1233, 1245]}, {"key": "agreements-or-arrangements", "type": "clause", "offset": [1263, 1289]}, {"key": "third-party-vendors", "type": "definition", "offset": [1295, 1314]}, {"key": "with-respect-to", "type": "clause", "offset": [1315, 1330]}, {"key": "a-third-party", "type": "clause", "offset": [1406, 1419]}, {"key": "not-assignable", "type": "clause", "offset": [1423, 1437]}, {"key": "in-no-event-shall", "type": "clause", "offset": [1574, 1591]}, {"key": "transition-completion-date", "type": "definition", "offset": [1658, 1684]}], "samples": [{"hash": "layIQjcDrux", "uri": "/contracts/layIQjcDrux#interim-supply", "label": "Termination Agreement (Kalobios Pharmaceuticals Inc)", "score": 26.3552361396, "published": true}, {"hash": "cTV1myUZlbk", "uri": "/contracts/cTV1myUZlbk#interim-supply", "label": "Termination Agreement (Kalobios Pharmaceuticals Inc)", "score": 25.8459958932, "published": true}], "size": 3, "hash": "4cf405d537c776add76a02152a5cb327", "id": 5}, {"snippet": "To the extent that and for so long as, notwithstanding Licensor\u2019s exercise of commercially reasonable efforts, Licensor is unable to cause its Third Party manufacturers to take any steps set forth in Sections 4.10.1(i)-(v), with the result that Licensee is materially impeded from, either by itself or through a Third Party manufacturer, Manufacturing Licensed Products or Licensed Compounds, Licensor shall supply Licensee with its reasonable requirements of such Licensed Compounds or Licensed Products at a price equal to Licensor\u2019s Manufacturing Costs for such Licensed Products or Licensed Compounds. Licensor\u2019s obligation under this Section 4.10.3 shall be conditioned upon Licensee providing Licensor with reasonable notification of its need for such supply. Licensor shall not be required to allocate such supply to Licensee in a manner that would have an adverse effect on the quantity of Initial Licensed Compound available to Licensor as necessary to fulfill Licensor\u2019s obligations under the Initial Development Plan.", "snippet_links": [{"key": "to-the-extent", "type": "clause", "offset": [0, 13]}, {"key": "exercise-of", "type": "clause", "offset": [66, 77]}, {"key": "commercially-reasonable-efforts", "type": "definition", "offset": [78, 109]}, {"key": "third-party-manufacturers", "type": "clause", "offset": [143, 168]}, {"key": "a-third-party", "type": "clause", "offset": [310, 323]}, {"key": "licensed-products", "type": "clause", "offset": [352, 369]}, {"key": "licensed-compounds", "type": "definition", "offset": [373, 391]}, {"key": "supply-licensee", "type": "definition", "offset": [408, 423]}, {"key": "to-licensor", "type": "clause", "offset": [522, 533]}, {"key": "manufacturing-costs", "type": "definition", "offset": [536, 555]}, {"key": "be-conditioned", "type": "clause", "offset": [660, 674]}, {"key": "upon-licensee", "type": "definition", "offset": [675, 688]}, {"key": "notification-of", "type": "definition", "offset": [724, 739]}, {"key": "to-licensee", "type": "definition", "offset": [821, 832]}, {"key": "effect-on-the", "type": "clause", "offset": [872, 885]}, {"key": "quantity-of", "type": "clause", "offset": [886, 897]}, {"key": "initial-licensed-compound", "type": "definition", "offset": [898, 923]}, {"key": "available-to", "type": "definition", "offset": [924, 936]}, {"key": "obligations-under-the", "type": "clause", "offset": [981, 1002]}, {"key": "initial-development-plan", "type": "definition", "offset": [1003, 1027]}], "samples": [{"hash": "fKAKLGdSSR2", "uri": "/contracts/fKAKLGdSSR2#interim-supply", "label": "License Agreement (Reata Pharmaceuticals Inc)", "score": 32.1587953457, "published": true}, {"hash": "5HftZb5eNaE", "uri": "/contracts/5HftZb5eNaE#interim-supply", "label": "License Agreement (Reata Pharmaceuticals Inc)", "score": 26.1026694045, "published": true}], "size": 3, "hash": "615a03e5c26f1f19ec2492172c5e9e05", "id": 6}, {"snippet": "The Customer acknowledges and agrees that, for any Interim Supply Period the: relevant Supplier may supply Energy Products on an interim basis pursuant to the relevant Customer Contract; and Authority may (and the Customer authorises the Authority to) agree the Interim Price with the Supplier on behalf of the Customer in accordance with the applicable Framework Agreement. Without prejudice to any specific provision of this Clause 3, the Customer shall: co-operate with the Authority; provide such other assistance to the Authority (including providing information at such times and in such formats as the Authority may require from time to time), as required by the Authority in order to: (i) meet its obligations; and/or exercise its rights under any Framework Agreement; and (ii) perform the Services. The co-operation and assistance referred to in Clause 3.14 shall include: on termination or expiry of a Framework Agreement giving such consents, taking such steps and doing such other things as are necessary to enable: if applicable the assignment, novation or other transfer of any Customer Contract from the relevant Supplier to a new supplier; the Registration of such new supplier as the supplier to the Customer of the relevant Energy Products under applicable Industry Documents at the relevant Supply Points; and/or the Authority to enter into a framework agreement with the new supplier for the purposes of supplying such Energy Products and/or Ancillary Services to Relevant Customers; providing such feedback, information and documentation on Suppliers and their performance under applicable Framework Agreements and/or Customer Contracts as the Authority may from time to time request; providing access to any Sites and employees, agents or sub-contractors of the Customer and such information, documentation and other evidence as is necessary to assist the Authority in carrying out an audit of a Supplier and its performance under any Framework Agreement and/or Customer Contract; providing access to any Sites and employees, agents or sub-contractors of the Customer and such information, documentation and other evidence as is necessary or useful (in the opinion of the Authority) to assist in any Dispute or claim made by or brought against the Authority (whether by a Supplier or a third party) arising out of or in connection with the applicable Framework Agreement and/or any Customer Contract, whether for breach of contract, negligence or other tort or otherwise; providing such assistance as the Authority requires in relation to AQ Reviews; providing information or documents to enable the Authority to provide the Managed Registration Information; promptly notifying the Authority of any changes to information provided to the Authority in accordance with the Authority\u2019s requirements from time to time; notifying the Authority as soon as practicable where the Customer plans to add or remove any of its Sites, or where it plans to vary or remove any Energy Products or Ancillary Services supplied by a Supplier to one or more of its Sites, or where it plans materially to increase or reduce its consumption of an Energy Product or where it wishes to be supplied with additional Energy Products and/or Ancillary Services to one or more of the Sites; and notifying the Authority if there is any dispute under any Customer Contract and consulting with the Authority before commencing any enforcement action pursuant to the Customer Contract and in appropriate circumstances the Parties shall agree on a course of action to be taken in order to resolve such dispute. The Customer shall co-operate with any investigation into: alleged inappropriate disclosure of Confidential Information; alleged use of Confidential Information not in accordance with public policy; alleged use or disclosure of Confidential Information which is not in accordance with this Agreement; alleged breaches of competition law; any regulatory matter; alleged criminal activity; or any other matter, that might be conducted by the Authority and/or any appropriate authority. If applicable, the Customer shall be responsible for the protection of any authentication materials, including usernames, passwords, PINs and private keys, and shall not provide or disclose such authentication materials to unauthorised parties. The Customer acknowledges and agrees that in the event of any persistent or serious breach the Authority may suspend the provision of some or all of the Services. In such circumstances the Customer shall remain liable for paying its Suppliers, and shall continue to comply with its obligations under any relevant Customer Contract, without recourse to the Authority. Without prejudice to any of its specific obligations under this Agreement or any Customer Contract, the Customer shall use all reasonable care, skill and diligence in undertaking its responsibilities under this Agreement and each Customer Contract. The Customer acknowledges and agrees that, in providing the Procurement Services and in fulfilling its obligations under this Agreement, the Authority does not provide any: advice to the Customer in relation to Transactions, the pricing of or risk associated with Energy Products; or investment or transactional advice. The Customer acknowledges and agrees that: any marketing activities carried out by the Authority may include contacting the Customer by telephone, post, email or otherwise; and the Authority is not required to comply with Regulations 9(1), 9(2) and 11 of the Electronic Commerce (EC Directive) Regulations 2002.", "snippet_links": [{"key": "customer-acknowledges-and-agrees", "type": "clause", "offset": [4, 36]}, {"key": "interim-supply-period", "type": "definition", "offset": [51, 72]}, {"key": "relevant-supplier", "type": "definition", "offset": [78, 95]}, {"key": "energy-products", "type": "clause", "offset": [107, 122]}, {"key": "the-relevant", "type": "clause", "offset": [155, 167]}, {"key": "interim-price", "type": "clause", "offset": [262, 275]}, {"key": "the-supplier", "type": "clause", "offset": [281, 293]}, {"key": "of-the-customer", "type": "clause", "offset": [304, 319]}, {"key": "in-accordance-with", "type": "definition", "offset": [320, 338]}, {"key": "the-applicable", "type": "clause", "offset": [339, 353]}, {"key": "without-prejudice-to-any", "type": "clause", "offset": [375, 399]}, {"key": "provision-of", "type": "clause", "offset": [409, 421]}, {"key": "clause-3", "type": "definition", "offset": [427, 435]}, {"key": "the-customer-shall", "type": "clause", "offset": [437, 455]}, {"key": "assistance-to-the-authority", "type": "clause", "offset": [507, 534]}, {"key": "providing-information", "type": "clause", "offset": [546, 567]}, {"key": "the-authority-may", "type": "clause", "offset": [605, 622]}, {"key": "from-time-to-time", "type": "clause", "offset": [631, 648]}, {"key": "by-the-authority", "type": "clause", "offset": [663, 679]}, {"key": "in-order-to", "type": "clause", "offset": [680, 691]}, {"key": "the-services", "type": "definition", "offset": [794, 806]}, {"key": "the-co", "type": "clause", "offset": [808, 814]}, {"key": "in-clause", "type": "clause", "offset": [852, 861]}, {"key": "expiry-of", "type": "clause", "offset": [900, 909]}, {"key": "if-applicable", "type": "clause", "offset": [1028, 1041]}, {"key": "the-assignment", "type": "clause", "offset": [1042, 1056]}, {"key": "transfer-of", "type": "definition", "offset": [1076, 1087]}, {"key": "new-supplier", "type": "definition", "offset": [1142, 1154]}, {"key": "the-registration", "type": "clause", "offset": [1156, 1172]}, {"key": "industry-documents", "type": "definition", "offset": [1275, 1293]}, {"key": "relevant-supply", "type": "definition", "offset": [1301, 1316]}, {"key": "authority-to-enter", "type": "clause", "offset": [1336, 1354]}, {"key": "for-the-purposes-of", "type": "clause", "offset": [1404, 1423]}, {"key": "ancillary-services", "type": "definition", "offset": [1462, 1480]}, {"key": "relevant-customers", "type": "definition", "offset": [1484, 1502]}, {"key": "information-and-documentation", "type": "clause", "offset": [1529, 1558]}, {"key": "performance-under", "type": "clause", "offset": [1582, 1599]}, {"key": "framework-agreements", "type": "definition", "offset": [1611, 1631]}, {"key": "customer-contracts", "type": "clause", "offset": [1639, 1657]}, {"key": "access-to", "type": "definition", "offset": [1716, 1725]}, {"key": "such-information", "type": "definition", "offset": [1797, 1813]}, {"key": "other-evidence", "type": "definition", "offset": [1833, 1847]}, {"key": "assist-the-authority", "type": "clause", "offset": [1867, 1887]}, {"key": "carrying-out-an-audit", "type": "clause", "offset": [1891, 1912]}, {"key": "a-supplier", "type": "definition", "offset": [1916, 1926]}, {"key": "of-the-authority", "type": "clause", "offset": [2187, 2203]}, {"key": "dispute-or-claim", "type": "clause", "offset": [2222, 2238]}, {"key": "a-third-party", "type": "clause", "offset": [2306, 2319]}, {"key": "arising-out-of", "type": "definition", "offset": [2321, 2335]}, {"key": "in-connection-with", "type": "clause", "offset": [2339, 2357]}, {"key": "breach-of-contract", "type": "definition", "offset": [2435, 2453]}, {"key": "in-relation-to", "type": "clause", "offset": [2546, 2560]}, {"key": "provide-the", "type": "clause", "offset": [2635, 2646]}, {"key": "managed-registration-information", "type": "definition", "offset": [2647, 2679]}, {"key": "information-provided", "type": "clause", "offset": [2732, 2752]}, {"key": "as-soon-as-practicable", "type": "definition", "offset": [2861, 2883]}, {"key": "where-the-customer", "type": "clause", "offset": [2884, 2902]}, {"key": "services-supplied", "type": "clause", "offset": [3013, 3030]}, {"key": "additional-energy", "type": "definition", "offset": [3201, 3218]}, {"key": "the-sites", "type": "clause", "offset": [3272, 3281]}, {"key": "enforcement-action", "type": "clause", "offset": [3419, 3437]}, {"key": "the-parties-shall", "type": "clause", "offset": [3505, 3522]}, {"key": "action-to-be-taken", "type": "clause", "offset": [3544, 3562]}, {"key": "use-of-confidential-information", "type": "clause", "offset": [3726, 3757]}, {"key": "public-policy", "type": "definition", "offset": [3781, 3794]}, {"key": "information-which", "type": "clause", "offset": [3838, 3855]}, {"key": "alleged-breaches", "type": "definition", "offset": [3898, 3914]}, {"key": "competition-law", "type": "definition", "offset": [3918, 3933]}, {"key": "regulatory-matter", "type": "definition", "offset": [3939, 3956]}, {"key": "criminal-activity", "type": "clause", "offset": [3966, 3983]}, {"key": "other-matter", "type": "clause", "offset": [3992, 4004]}, {"key": "appropriate-authority", "type": "definition", "offset": [4058, 4079]}, {"key": "responsible-for", "type": "clause", "offset": [4118, 4133]}, {"key": "protection-of", "type": "definition", "offset": [4138, 4151]}, {"key": "private-keys", "type": "definition", "offset": [4223, 4235]}, {"key": "in-the-event-of", "type": "definition", "offset": [4368, 4383]}, {"key": "serious-breach", "type": "clause", "offset": [4402, 4416]}, {"key": "without-recourse", "type": "clause", "offset": [4658, 4674]}, {"key": "agreement-or", "type": "definition", "offset": [4757, 4769]}, {"key": "reasonable-care", "type": "clause", "offset": [4820, 4835]}, {"key": "its-responsibilities", "type": "clause", "offset": [4872, 4892]}, {"key": "providing-the", "type": "clause", "offset": [4988, 5001]}, {"key": "services-and", "type": "clause", "offset": [5014, 5026]}, {"key": "associated-with", "type": "definition", "offset": [5190, 5205]}, {"key": "activities-carried", "type": "clause", "offset": [5319, 5337]}, {"key": "by-telephone", "type": "definition", "offset": [5395, 5407]}, {"key": "to-comply-with-regulations", "type": "clause", "offset": [5469, 5495]}, {"key": "electronic-commerce", "type": "clause", "offset": [5521, 5540]}, {"key": "ec-directive", "type": "definition", "offset": [5542, 5554]}], "samples": [{"hash": "f7cTOTpLsbQ", "uri": "/contracts/f7cTOTpLsbQ#interim-supply", "label": "Customer Access Agreement", "score": 21.4517453799, "published": true}, {"hash": "gE5LxyufAru", "uri": "/contracts/gE5LxyufAru#interim-supply", "label": "Customer Access Agreement", "score": 21.4106776181, "published": true}], "size": 2, "hash": "5cb2e9aef4c81c67d6f7341f2d3349c0", "id": 7}, {"snippet": "At Shire\u2019s written request, Mirum shall use Commercially Reasonable Efforts to facilitate the supply to Shire, from either Mirum (or its Affiliates) or from Mirum\u2019s contract manufacturers, of Shire\u2019s requirements for Compound and Licensed Product for a period of [\u2026***\u2026], provided that, except in the case of termination by Shire for Mirum\u2019s material breach pursuant to Section 8.2, Shire reimburses Mirum for all reasonable out-of-pocket costs incurred by Mirum in connection with such activities.", "snippet_links": [{"key": "written-request", "type": "definition", "offset": [11, 26]}, {"key": "use-commercially-reasonable-efforts", "type": "clause", "offset": [40, 75]}, {"key": "contract-manufacturers", "type": "definition", "offset": [165, 187]}, {"key": "requirements-for", "type": "clause", "offset": [200, 216]}, {"key": "licensed-product", "type": "clause", "offset": [230, 246]}, {"key": "period-of", "type": "definition", "offset": [253, 262]}, {"key": "provided-that", "type": "clause", "offset": [272, 285]}, {"key": "in-the-case", "type": "clause", "offset": [294, 305]}, {"key": "termination-by-shire", "type": "clause", "offset": [309, 329]}, {"key": "material-breach", "type": "clause", "offset": [342, 357]}, {"key": "section-82", "type": "clause", "offset": [370, 381]}, {"key": "costs-incurred", "type": "definition", "offset": [439, 453]}, {"key": "in-connection-with", "type": "clause", "offset": [463, 481]}], "samples": [{"hash": "irFgvF0jpzg", "uri": "/contracts/irFgvF0jpzg#interim-supply", "label": "Assignment and License Agreement", "score": 31.340862423, "published": true}, {"hash": "e2dosnUQXf8", "uri": "/contracts/e2dosnUQXf8#interim-supply", "label": "Assignment and License Agreement (Mirum Pharmaceuticals, Inc.)", "score": 30.2922655715, "published": true}], "size": 2, "hash": "8bfb8a0a045b763296811edd55a105da", "id": 8}, {"snippet": "At KaloBios\u2019 request, Sanofi shall supply, or cause to be supplied, to KaloBios sufficient quantities of Licensed Products to satisfy KaloBios\u201d and its Affiliates\u2019 and sublicensees\u2019 requirements for Licensed Product for a period of the earlier of (i) when KaloBios is able to manufacture or have manufacture Licensed Products itself or (ii) two (2) years following the effective date of termination; provided that KaloBios shall use Commercially Reasonable Efforts to affect such assumption (or transition) as promptly as practicable. Such supply shall be at a price equal to [***] for such Licensed Product(s). Any such supply will be made pursuant to a supply agreement between the Parties with typical provisions relating to quality, forecasting and ordering to forecast, force majeure and product liability and indemnity. In the event that Sanofi has one or more agreements with Third Party manufacturers with respect to the manufacture of a Licensed Product, at KaloBios\u201d request, Sanofi shall use Commercially Reasonable Efforts to transfer its rights and obligations under such agreement(s) to KaloBios upon any such termination.", "snippet_links": [{"key": "licensed-products", "type": "clause", "offset": [105, 122]}, {"key": "requirements-for", "type": "clause", "offset": [182, 198]}, {"key": "period-of", "type": "definition", "offset": [222, 231]}, {"key": "to-manufacture", "type": "definition", "offset": [273, 287]}, {"key": "effective-date-of-termination", "type": "clause", "offset": [369, 398]}, {"key": "provided-that", "type": "clause", "offset": [400, 413]}, {"key": "use-commercially-reasonable-efforts", "type": "clause", "offset": [429, 464]}, {"key": "equal-to", "type": "definition", "offset": [567, 575]}, {"key": "pursuant-to-a", "type": "definition", "offset": [641, 654]}, {"key": "agreement-between-the-parties", "type": "clause", "offset": [662, 691]}, {"key": "provisions-relating-to", "type": "clause", "offset": [705, 727]}, {"key": "forecasting-and-ordering", "type": "clause", "offset": [737, 761]}, {"key": "force-majeure", "type": "definition", "offset": [775, 788]}, {"key": "product-liability-and-indemnity", "type": "clause", "offset": [793, 824]}, {"key": "in-the-event", "type": "clause", "offset": [826, 838]}, {"key": "third-party-manufacturers", "type": "clause", "offset": [883, 908]}, {"key": "with-respect-to", "type": "clause", "offset": [909, 924]}, {"key": "to-transfer", "type": "clause", "offset": [1035, 1046]}, {"key": "rights-and-obligations", "type": "definition", "offset": [1051, 1073]}], "samples": [{"hash": "fQlDbC9TTOi", "uri": "/contracts/fQlDbC9TTOi#interim-supply", "label": "Development, Commercialization Collaboration and License Agreement (Kalobios Pharmaceuticals Inc)", "score": 23.598220397, "published": true}, {"hash": "jcrNQjo5Clo", "uri": "/contracts/jcrNQjo5Clo#interim-supply", "label": "Development, Commercialization Collaboration and License Agreement (Kalobios Pharmaceuticals Inc)", "score": 23.4449007529, "published": true}], "size": 2, "hash": "0161a9372c414adb0fe148e9e49b8293", "id": 9}, {"snippet": "In the case where Alder notifies BMS in writing within [***] after the date of termination that Alder desires BMS to provide to Alder an interim supply of Licensed Compound and/or Cancer Product, BMS shall use Diligent Efforts to provide such supply in accordance with the terms of this Section 13.6(g). BMS\u2019 obligation to provide such supply under this Section 13.6(g) shall only be for the period of [***] from the date of termination and BMS shall have no obligation to supply Licensed Compound and/or Cancer Product to Alder after such [***] or, if earlier, Alder\u2019s notification to BMS that Alder has obtained alternative, validated source of supply of Licensed Compound and/or Cancer Product, as applicable. Upon such request by Alder for such interim supply, the Parties shall enter into a supply agreement pursuant to which BMS will use Diligent Efforts to supply Licensed Compound and/or Product to Alder for such period ending [***] after the termination date,. Alder shall use all reasonable commercial efforts to procure an alternative supply of Licensed Compound and/or Cancer Product as soon as possible following the effective date of the applicable termination. The Licensed Compound and/or Cancer Product shall be supplied at a supply price equal to BMS\u2019 Manufacturing Costs for such Licensed Compound or Cancer Product supplied. The supply agreement shall reflect these provisions and shall contain such other customary terms as the Parties deem appropriate.", "snippet_links": [{"key": "in-the-case", "type": "clause", "offset": [0, 11]}, {"key": "in-writing", "type": "clause", "offset": [37, 47]}, {"key": "date-of-termination", "type": "clause", "offset": [71, 90]}, {"key": "supply-of-licensed-compound", "type": "clause", "offset": [145, 172]}, {"key": "cancer-product", "type": "definition", "offset": [180, 194]}, {"key": "diligent-efforts", "type": "definition", "offset": [210, 226]}, {"key": "in-accordance-with", "type": "definition", "offset": [250, 268]}, {"key": "terms-of", "type": "definition", "offset": [273, 281]}, {"key": "obligation-to-provide", "type": "clause", "offset": [309, 330]}, {"key": "period-of", "type": "definition", "offset": [392, 401]}, {"key": "termination-and", "type": "clause", "offset": [425, 440]}, {"key": "no-obligation-to-supply", "type": "clause", "offset": [456, 479]}, {"key": "notification-to", "type": "clause", "offset": [570, 585]}, {"key": "source-of-supply", "type": "definition", "offset": [637, 653]}, {"key": "the-parties-shall", "type": "clause", "offset": [765, 782]}, {"key": "pursuant-to", "type": "definition", "offset": [813, 824]}, {"key": "period-ending", "type": "definition", "offset": [922, 935]}, {"key": "after-the-termination-date", "type": "clause", "offset": [942, 968]}, {"key": "reasonable-commercial-efforts", "type": "definition", "offset": [991, 1020]}, {"key": "alternative-supply", "type": "clause", "offset": [1035, 1053]}, {"key": "as-soon-as-possible", "type": "definition", "offset": [1097, 1116]}, {"key": "applicable-termination", "type": "definition", "offset": [1153, 1175]}, {"key": "supply-price", "type": "definition", "offset": [1244, 1256]}, {"key": "equal-to", "type": "definition", "offset": [1257, 1265]}, {"key": "manufacturing-costs", "type": "definition", "offset": [1271, 1290]}, {"key": "the-supply-agreement", "type": "clause", "offset": [1346, 1366]}, {"key": "other-customary-terms", "type": "clause", "offset": [1421, 1442]}], "samples": [{"hash": "65Tpka9XIGr", "uri": "/contracts/65Tpka9XIGr#interim-supply", "label": "Collaboration and License Agreement (Alder Biopharmaceuticals Inc)", "score": 25.3285420945, "published": true}, {"hash": "hmRsDoxl6P3", "uri": "/contracts/hmRsDoxl6P3#interim-supply", "label": "Collaboration and License Agreement (Alder Biopharmaceuticals Inc)", "score": 25.2108145106, "published": true}], "size": 2, "hash": "f2f40d3ae558cc2ecab8e59663bf3595", "id": 10}], "next_curs": "ClcSUWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjMLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IhdpbnRlcmltLXN1cHBseSMwMDAwMDAwYQyiAQJlbhgAIAA=", "clause": {"parents": [["term-and-termination", "Term and Termination"], ["manufacture-and-supply", "Manufacture and Supply"], ["licenses-and-payments-on-termination", "Licenses and Payments on Termination"], ["consequences-of-termination-by-sanofi", "Consequences of Termination By Sanofi"], ["manufacturing", "Manufacturing"]], "children": [["form-of-product-and-price", "Form of Product and Price"], ["governmental-authority-inspection", "Governmental Authority Inspection"], ["audit-and-inspection", "Audit and Inspection"], ["inventory-transfer", "Inventory Transfer"], ["governmental-authority-action", "Governmental Authority Action"]], "size": 45, "title": "Interim Supply", "id": "interim-supply", "related": [["master-services-agreement", "Master Services Agreement", "Master Services Agreement"], ["transition-services-agreement", "Transition Services Agreement", "Transition Services Agreement"], ["subservicing-agreements-between-the-servicer-and-subservicers", "Subservicing Agreements between the Servicer and Subservicers", "Subservicing Agreements between the Servicer and Subservicers"], ["services-agreement", "Services Agreement", "Services Agreement"], ["of-the-interim-servicing-agreement", "of the Interim Servicing Agreement", "of the Interim Servicing Agreement"]], "related_snippets": [], "updated": "2025-07-07T12:36:18+00:00", "also_ask": [], "drafting_tip": null, "explanation": "The Interim Supply clause establishes the obligation for a supplier to continue providing goods or services on a temporary basis, typically during a transitional period such as contract renewal negotiations or following contract termination. In practice, this clause may require the supplier to maintain existing service levels for a defined period or until a new provider is in place, ensuring no disruption to the recipient\u2019s operations. Its core function is to guarantee continuity of supply and minimize operational risks during periods of contractual uncertainty or change."}, "json": true, "cursor": ""}}